| Bivalirudin | 🇺🇸United States | 250MG/VIAL | injectable | Marketed | Eugia Pharma |
| Bivalirudin | 🇺🇸United States | 250MG/VIAL | injectable | Tentative approval | Mylan Labs LTD |
| Bivalirudin | 🇨🇦Canada | 250 MG / VIAL | Powder For Solution | Cancelled | Sandoz Canada Incorporated |
| Bivalirudina Hikma | 🇮🇹Italy | | Polvere per concentrato per soluzione iniettabile/infusione | Authorised | Hikma Farmaceutica (Portugal) S.A. |
| Bivalirudina Accord | 🇮🇹Italy | | polvere per concentrato e soluzione per soluzione per infusione | Authorised | Accord Healthcare, S.L.U. |
| Bivalirudin Injection | 🇨🇦Canada | 5 MG / ML | Solution | Marketed | Avir Pharma INC. |
| Bivalirudin for Injection | 🇨🇦Canada | 250 MG / VIAL | Powder For Solution | Marketed | Fresenius Kabi Canada LTD |
| Bivalirudin for Injection | 🇨🇦Canada | 250 MG / VIAL | Powder For Solution | Marketed | Juno Pharmaceuticals Corp. |
| Bivalirudin for Injection | 🇨🇦Canada | 250 MG / VIAL | Powder For Solution | Marketed | Formative Pharma INC. |
| Bivalirudin in 0.9% Sodium Chloride | 🇺🇸United States | 250MG/50ML, 500MG/100ML | solution | Not marketed | Baxter Hlthcare Corp |
| Bivalirudina Sala 250 MG Polvo Para Concentrado Para Solucion Inyectable O Perfusion Efg | 🇪🇸Spain | 250 mg | polvo para concentrado para solucion inyectable y para perfusion | Marketed | Laboratorio Reig Jofre, S.A. |
| Bivalirudine Hikma 250 mg poeder voor concentraat voor oplossing voor injectie/infusie | 🇳🇱Netherlands | | Poeder voor concentraat voor oplossing voor injectie / infusie | Authorised | Hikma Farmaceutica (Portugal), S.A. |
| Bivalirudine Accord 250 mg poeder voor concentraat voor oplossing voor injectie/infusie | 🇳🇱Netherlands | | Poeder voor concentraat voor oplossing voor injectie / infusie | Authorised | Accord Healthcare B.V. |
| Bivalirudine Splendris 250 mg poeder voor concentraat voor oplossing voor injectie of infusie | 🇳🇱Netherlands | | Poeder voor oplossing voor injectie of infusie | Authorised | Splendris Pharmaceuticals GmbH |
| Bivalirudina Hikma 250 MG Polvo Para Concentrado Para Solución Inyectable O Perfusión Efg | 🇪🇸Spain | 250 mg | polvo para concentrado para solución inyectable y para perfusión | Authorised | Hikma Farmaceutica (Portugal) S.A. |
| Bivalirudin for Injection | 🇨🇦Canada | 250 MG / VIAL | Powder For Solution | Cancelled | DR Reddy'S Laboratories LTD |
| Bivalirudina Accord 250 MG de Polvo Para Concentrado Para Solucion Inyectable y Para Perfusion Efg | 🇪🇸Spain | 250,000 mg | polvo para concentrado para solucion inyectable y para perfusion | Withdrawn | Accord Healthcare S.L.U. |
| Angiomax | 🇺🇸United States | 250MG/VIAL | injectable | Marketed | Sandoz |
| Angiomax Rtu | 🇺🇸United States | 250MG/50ML | solution | Marketed | Maia Pharms INC |
| Angiomax | 🇨🇦Canada | 250 MG / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Any | 🇳🇿New Zealand | | Inj 250 mg vial | Funded | |
| Angiox | 🇪🇺European Union | | | Withdrawn | The Medicines Company UK Ltd |
| ANGIOX 250 mg powder for concentrate for solution for infusion | 🇸🇦Saudi Arabia | | | Authorised | Patheon |
